Pål-Dag Line

Trials

Studies that name Pål-Dag Line as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:26 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT06850753 · En Bloc Resection of the Liver and Pancreas With a "Non-touch" Technique Followed by Liver Transplantation to Improve the Overall Survival in Patients With Non-resectable Hilar Cholangiocarcinoma Beyond the Mayo Clinic Transplant Criteria

  Oslo University Hospital · recruiting · Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Recurrent, Liver Transplantation · study chair
• Ph1/Ph2
  NCT04806737 · Teriflunomide vs. Placebo During Gluten Challenge in Celiac Disease

  Oslo University Hospital · completed · Celiac Disease · study chair

Grants

NIH projects from RePORTER, fetched 2026-11-12 08:26 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.